Suppression of Mast Cell Activation by Glucocorticoid
- 242 Downloads
Mast cells play a critical role in allergic diseases. When mast cells are activated by cross-linking of their high affinity IgE receptors by the antigen and IgE antibodies, release of chemical mediators is followed by secretion of multiple cytokines. We report that IL-3-dependent mucosal-type mast cells undergo apoptosis when IL-3 is withdrawn. In addition, cross-linking of high affinity IgE receptors prevents apoptosis of mast cells by paracrine mechanisms, producing IL-3, IL-4 and granulocyte/macrophage colony-stimulating factor (GM-CSF). However, the secretion of endogenous growth factors are not enough for cell survival, whereas IL-4 induces cell aggregation by expressing adhesion molecules such as leukocyte function-associated antigen 1 (LFA-1), and makes it reactive to endogenous growth factors by contact cell to cell interaction. On the other hand, dexamethazone down-regulates the expression of intracelluar adhesion molecule 1 (ICAM-1) and IL-4 in activated mast cells, by which the self-aggregation of mast cells is inhibited and apoptosis is induced. Thus, glucocorticoids suppress mast cell survival by inhibiting IL-4 production and expression of adhesion molecules.
Key wordsallergy mast cell glucocorticoid cytokine adhesion molecule.
Unable to display preview. Download preview PDF.
- Bradding P., Feather I. H., Howarth P. H., Mueller R., Roberts J. A., Britten K., Bews J. P. A., Hunt T. C., Okayama Y., Heusser C. H., Bullock G. R., Church M. K. and Holgate S. T. (1992): Interleukin 4 is localized to and released by human mast cells. J. Exp. Med., 176, 1381–1386.PubMedCrossRefGoogle Scholar
- Cronstein B. N., Kimmel S. C., Levin R. I., Martiniuk E and Weissmann G. (1992): A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA, 89, 9991–9995.PubMedCrossRefGoogle Scholar
- Kraneveld A. D., Ark I. V., Linde H. J. V. D., Fattah D., Nijkamp R. P. and Oosterhout A. J. M. V. (1997): Antibody to very late activation antigen 4 prevents interleukin-5-induced airway hyperresponsiveness and eosinophil infiltration in the airways of guinea pigs. J. Allergy Clin. Immunol., 100, 242–250.PubMedCrossRefGoogle Scholar
- Paliogianni F., Raptis A., Ahuja S. S., Najjar S. M. and Boumpas D. T. (1993): Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J. Clin. Invest., 91, 1481–1489.PubMedCrossRefGoogle Scholar
- Piccinni M. P., Macchia D., Parronchi P., Giudizi M. G., Bani D., Alterini R., Grossi A., Ricci M., Maggi E. and Romagnani S. (1991): Human bone-marrow non B, non T-cells produce interleukin 4 in response to cross-linkage of Fcc and Fcy receptors. Proc. Natl. Acad. Sci. USA, 88, 8656–8660.PubMedCrossRefGoogle Scholar
- Romagnani S. (1992): Induction of Thl and Th2 responses: a key role for the “natural” immune response? Immunol. Today, 13, 379–381.Google Scholar
- Valent P., Spanblochel E., Sperr W. R., Sillaber C., Zsebo K. M., Agis H., Strobl H., Geissler K., Bettelheim P. and Lechner K. (1992): Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood, 80, 2237–2245.PubMedGoogle Scholar